detalle del documento
IDENTIFICACIÓN

oai:pubmedcentral.nih.gov:1121...

Tema
Article
Autor
Reddy, Kavidha Lee, Guinevere Q. Reddy, Nicole Chikowore, Tatenda J.B. Baisley, Kathy Dong, Krista L. Walker, Bruce D. Yu, Xu G. Lichterfeld, Mathias Ndung’u, Thumbi
Langue
en
Editor

Cold Spring Harbor Laboratory

Categoría

medrxiv

Año

2024

fecha de cotización

3/7/2024

Palabras clave
untreated compared initiation p=0 initiated treated intact genomes total treatment late hiv decay reservoir hiv-1 art dna
Métrico

Resumen

BACKGROUND: Persisting HIV reservoir viruses in resting CD4 T cells and other cellular subsets are the main barrier to cure efforts.

Antiretroviral therapy (ART) intensification by early initiation has been shown to enable post-treatment viral control in some cases but the underlying mechanisms are not fully understood.

We hypothesized that ART initiated during the hyperacute phase of infection before peak will affect the size, decay dynamics and landscape characteristics of HIV-1 subtype C viral reservoirs.

METHODS: We studied 35 women at high risk of infection from Durban, South Africa identified with hyperacute HIV infection by twice weekly testing for plasma HIV-1 RNA.

Study participants included 11 who started ART at a median of 456 (297-1203) days post onset of viremia (DPOV), and 24 who started ART at a median of 1 (1-3) DPOV.

We used peripheral blood mononuclear cells (PBMC) to measure total HIV-1 DNA by ddPCR and to sequence reservoir viral genomes by full length individual proviral sequencing (FLIP-seq) from onset of detection of HIV up to 1 year post treatment initiation.

RESULTS: Whereas ART in hyperacute infection blunted peak viremia compared to untreated individuals (p<0.0001), there was no difference in total HIV-1 DNA measured contemporaneously (p=0.104).

There was a steady decline of total HIV DNA in early treated persons over 1 year of ART (p=0.0004), with no significant change observed in the late treated group.

Total HIV-1 DNA after one year of treatment was lower in the early treated compared to the late treated group (p=0.02).

Generation of 697 single viral genome sequences revealed a difference in the longitudinal proviral genetic landscape over one year between untreated, late treated, and early treated infection: the relative contribution of intact genomes to the total pool of HIV-1 DNA after 1 year was higher in untreated infection (31%) compared to late treated (14%) and early treated infection (0%).

Treatment initiated in both late and early infection resulted in a more rapid decay of intact (13% and 51% per month) versus defective (2% and 35% per month) viral genomes.

However, intact genomes were still observed one year post chronic treatment initiation in contrast to early treatment where intact genomes were no longer detectable.

Moreover, early ART reduced phylogenetic diversity of intact genomes and limited the seeding and persistence of cytotoxic T lymphocyte immune escape variants in the reservoir.

CONCLUSIONS: Overall, our results show that whereas ART initiated in hyperacute HIV-1 subtype C infection did not impact reservoir seeding, it was nevertheless associated with more rapid decay of intact viral genomes, decreased genetic complexity and immune escape in reservoirs, which could accelerate reservoir clearance when combined with other interventional strategies.

Reddy, Kavidha,Lee, Guinevere Q.,Reddy, Nicole,Chikowore, Tatenda J.B.,Baisley, Kathy,Dong, Krista L.,Walker, Bruce D.,Yu, Xu G.,Lichterfeld, Mathias,Ndung’u, Thumbi, 2024, Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection, Cold Spring Harbor Laboratory

Compartir

Fuente

Artículos recomendados por ES/IODE IA

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder